Home / Peptide Library

The Peptide Library.

A working reference of the peptides we prescribe and research. Each entry includes mechanism, evidence base, regulatory status, and typical use cases.

FILTER → All Antimicrobial Bone Cardiovascular Cognitive GI Hormonal Immune Longevity Metabolic Oncology Pain Performance Recovery Sexual Health Skin Sleep

A

Peptide	Primary Use	Category	Status	At The Tide
Abaloparatide Tymlos	PTHrP analog for osteoporosis.	Bone	FDA Approved	Out of Scope	Read
Acetyl tetrapeptide-3 Capixyl component	Hair follicle peptide for hair density.	Skin	Cosmetic	Out of Scope	Read
Angiotensin II Giapreza	Vasopressor for septic shock; ICU use only.	Cardiovascular	FDA Approved	Out of Scope	Read
AOD-9604 Growth hormone fragment 177–191	Targeted lipolysis without GH-like side effects in preclinical models.	Metabolic	Compounded	Prescribed	Read
Argireline Acetyl hexapeptide-8	Topical muscle-relaxing cosmetic peptide.	Skin	Cosmetic	Out of Scope	Read
Atrial natriuretic peptide ANP · Carperitide	Cardiac peptide hormone; heart failure research.	Cardiovascular	Research Only	Reference	Read
Aviptadil RLF-100 · Zyesami	VIP analog for pulmonary conditions; emergency COVID research.	Cardiovascular	Research Only	Reference	Read

B

Peptide	Primary Use	Category	Status	At The Tide
Bimatoprost Latisse	Prostaglandin analog for eyelash growth.	Skin	FDA Approved	Out of Scope	Read
Bortezomib Velcade	Proteasome inhibitor for multiple myeloma.	Oncology	FDA Approved	Out of Scope	Read
BPC-157 Body Protective Compound · PL 14736	A 15-amino-acid peptide with strong preclinical evidence for soft-tissue and gut repair.	Recovery	Compounded	Prescribed	Read
Bremelanotide PT-141 · Vyleesi	Central melanocortin pathway for sexual desire.	Sexual Health	FDA Approved	Prescribed	Read

C

Peptide	Primary Use	Category	Status	At The Tide
Cagrilintide AM833	Long-acting amylin analog; combined with semaglutide in trials.	Metabolic	Research Only	Reference	Read
Calcitonin salmon Miacalcin · Fortical	Salmon calcitonin for osteoporosis and Paget disease.	Bone	FDA Approved	Out of Scope	Read
Cathelicidins LL-37 family	Antimicrobial peptide class.	Antimicrobial	Research Only	Reference	Read
Cenderitide CD-NP	Designer natriuretic peptide; heart failure research.	Cardiovascular	Research Only	Reference	Read
Cerebrolysin Neurotrophic peptide mix	Cognitive and neurological recovery; case-by-case indication.	Cognitive	Compounded	Prescribed	Read
Cetrorelix Cetrotide	GnRH antagonist for IVF protocols.	Hormonal	FDA Approved	Out of Scope	Read
CJC-1295 Modified GRF 1-29 (no DAC)	Pulsatile GH release when paired with ipamorelin.	Performance	Compounded	Prescribed	Read
CJC-1295 with DAC CJC-1295 DAC	Long-acting GHRH analog with extended half-life.	Performance	Compounded	Reference	Read
Colistimethate Coly-Mycin	Polypeptide antibiotic for multidrug-resistant gram-negative infections.	Antimicrobial	FDA Approved	Out of Scope	Read
Copper tripeptide-1 GHK-Cu (cosmetic form)	Topical formulation of GHK-Cu for cosmetic use.	Skin	Cosmetic	Reference	Read
Corticotropin H.P. Acthar Gel · ACTH	Adrenocorticotropic hormone for infantile spasms and MS relapse.	Hormonal	FDA Approved	Out of Scope	Read

D

Peptide	Primary Use	Category	Status	At The Tide
Dalbavancin Dalvance	Long-acting lipoglycopeptide for skin infections.	Antimicrobial	FDA Approved	Out of Scope	Read
Daptomycin Cubicin	Cyclic lipopeptide antibiotic for gram-positive infections.	Antimicrobial	FDA Approved	Out of Scope	Read
Defensins Alpha/beta defensins	Endogenous antimicrobial peptides; research category.	Antimicrobial	Research Only	Reference	Read
Degarelix Firmagon	GnRH antagonist for prostate cancer.	Oncology	FDA Approved	Out of Scope	Read
Desmopressin DDAVP · Stimate	Synthetic vasopressin analog for diabetes insipidus and bleeding disorders.	Hormonal	FDA Approved	Out of Scope	Read
Dihexa PNB-0408	Angiotensin IV analog; preclinical cognitive data.	Cognitive	Research Only	Reference	Read
DSIP Delta sleep-inducing peptide	Sleep architecture and HPA-axis modulation.	Sleep	Compounded	Prescribed	Read
Dulaglutide Trulicity	Once-weekly GLP-1 agonist for type 2 diabetes.	Metabolic	FDA Approved	Reference	Read

E

Peptide	Primary Use	Category	Status	At The Tide
Enfuvirtide Fuzeon	HIV fusion inhibitor.	Antimicrobial	FDA Approved	Out of Scope	Read
Epitalon Epithalon · pineal tetrapeptide	Telomerase modulation in preclinical studies; longevity protocols.	Longevity	Compounded	Out of Scope	Read
Exenatide Byetta · Bydureon	GLP-1 agonist for type 2 diabetes management.	Metabolic	FDA Approved	Reference	Read

F

Peptide	Primary Use	Category	Status	At The Tide
FOXO4-DRI Senolytic peptide	Senolytic peptide; senescent cell clearance research.	Longevity	Research Only	Reference	Read

G

Peptide	Primary Use	Category	Status	At The Tide
Ganirelix Ganirelix acetate	GnRH antagonist for controlled ovarian stimulation.	Hormonal	FDA Approved	Out of Scope	Read
GHK-Cu Copper tripeptide-1	Collagen synthesis, wound healing, dermatologic use.	Skin	Compounded	Prescribed	Read
GHRP-2 Pralmorelin	Growth hormone releasing peptide; strong GH spike.	Performance	Compounded	Reference	Read
GHRP-6 Hexapeptide-2	Growth hormone releasing peptide; appetite stimulation.	Performance	Compounded	Reference	Read
Glucagon GlucaGen · Baqsimi · Gvoke	Pancreatic peptide hormone for severe hypoglycemia.	Metabolic	FDA Approved	Out of Scope	Read
Gonadorelin GnRH · Factrel	Synthetic GnRH for fertility workup and hormone support.	Hormonal	FDA Approved	Prescribed	Read
Goserelin Zoladex	GnRH agonist depot implant for prostate and breast cancer.	Oncology	FDA Approved	Out of Scope	Read

H

Peptide	Primary Use	Category	Status	At The Tide
HCG Human chorionic gonadotropin	Peptide hormone for fertility and male hormone support.	Hormonal	FDA Approved	Prescribed	Read
Hexarelin Examorelin	Potent GHRP; cortisol risk limits long-term use.	Performance	Compounded	Reference	Read
HGH Fragment 176-191 AOD variant	GH fragment targeting fat metabolism.	Metabolic	Compounded	Reference	Read
Histrelin Vantas · Supprelin LA	GnRH agonist implant for central precocious puberty and prostate cancer.	Oncology	FDA Approved	Out of Scope	Read
Humanin Mitochondrial-derived peptide	Cytoprotective mitochondrial peptide; longevity research.	Longevity	Research Only	Reference	Read

I

Peptide	Primary Use	Category	Status	At The Tide
Insulin aspart Novolog · Fiasp	Rapid-acting insulin analog for diabetes.	Metabolic	FDA Approved	Out of Scope	Read
Insulin degludec Tresiba	Ultra-long-acting basal insulin for diabetes.	Metabolic	FDA Approved	Out of Scope	Read
Insulin glargine Lantus · Basaglar	Long-acting basal insulin for diabetes.	Metabolic	FDA Approved	Out of Scope	Read
Insulin lispro Humalog · Admelog	Rapid-acting insulin analog for diabetes.	Metabolic	FDA Approved	Out of Scope	Read
Ipamorelin Selective GHRP	Selective GH release without cortisol or prolactin elevation.	Performance	Compounded	Prescribed	Read

K

Peptide	Primary Use	Category	Status	At The Tide
Kisspeptin KP-10 · Kisspeptin-54	Upstream HPG axis signaling; fertility and libido research.	Hormonal	Compounded	Prescribed	Read
KPV Lysine-proline-valine tripeptide	Anti-inflammatory tripeptide; gut and skin applications.	Recovery	Compounded	Prescribed	Read

L

Peptide	Primary Use	Category	Status	At The Tide
Lactoferrin peptides Lactoferricin fragments	Antimicrobial and immunomodulatory peptide fragments.	Immune	Research Only	Reference	Read
Lanreotide Somatuline Depot	Long-acting somatostatin analog for acromegaly and NETs.	Hormonal	FDA Approved	Out of Scope	Read
Leuprolide Lupron · Eligard	GnRH agonist for prostate cancer, endometriosis, and IVF.	Oncology	FDA Approved	Out of Scope	Read
Linaclotide Linzess	Guanylate cyclase-C agonist for IBS-C and chronic constipation.	GI	FDA Approved	Out of Scope	Read
Liraglutide Victoza · Saxenda	Daily GLP-1 agonist for type 2 diabetes and obesity.	Metabolic	FDA Approved	Reference	Read
Lixisenatide Adlyxin	Once-daily GLP-1 agonist for type 2 diabetes.	Metabolic	FDA Approved	Reference	Read
LL-37 Cathelicidin	Antimicrobial peptide; chronic infection-focused protocols.	Antimicrobial	Compounded	Prescribed	Read
Lutetium Lu 177 dotatate Lutathera	Radiolabeled somatostatin analog for gastroenteropancreatic NETs.	Oncology	FDA Approved	Out of Scope	Read

M

Peptide	Primary Use	Category	Status	At The Tide
Macimorelin Macrilen	Oral ghrelin agonist for GH deficiency diagnosis.	Hormonal	FDA Approved	Out of Scope	Read
Matrixyl Palmitoyl pentapeptide-4	Topical collagen-stimulating cosmetic peptide.	Skin	Cosmetic	Out of Scope	Read
Mazdutide LY3305677 · IBI362	Dual GLP-1/glucagon agonist; phase 3 trials.	Metabolic	Research Only	Reference	Read
Melanotan I Afamelanotide · Scenesse	Melanocortin analog approved for erythropoietic protoporphyria.	Skin	FDA Approved	Out of Scope	Read
Melanotan II MT-II	Melanocortin agonist for pigmentation and libido; significant safety concerns.	Skin	Research Only	Reference	Read
MK-677 Ibutamoren	Oral ghrelin receptor agonist; sustained GH/IGF-1 elevation.	Performance	Research Only	Reference	Read
MOTS-c Mitochondrial-derived peptide	Metabolic regulation, insulin sensitivity, mitochondrial function.	Metabolic	Compounded	Prescribed	Read

N

Peptide	Primary Use	Category	Status	At The Tide
N-Acetyl Selank Amidate NA-Selank-Amidate	Stabilized Selank analog with longer duration.	Cognitive	Research Only	Reference	Read
N-Acetyl Semax Amidate NA-Semax-Amidate	Stabilized Semax analog with longer duration.	Cognitive	Research Only	Reference	Read
Nafarelin Synarel	Nasal GnRH agonist for endometriosis and precocious puberty.	Hormonal	FDA Approved	Out of Scope	Read
Nesiritide Natrecor	Recombinant BNP for acute decompensated heart failure.	Cardiovascular	FDA Approved	Out of Scope	Read
Noopept GVS-111	Dipeptide nootropic; technically a peptide derivative.	Cognitive	Research Only	Reference	Read

O

Peptide	Primary Use	Category	Status	At The Tide
Octreotide Sandostatin	Somatostatin analog for acromegaly, carcinoid, and VIPoma.	Hormonal	FDA Approved	Out of Scope	Read
Oritavancin Orbactiv · Kimyrsa	Single-dose lipoglycopeptide for skin infections.	Antimicrobial	FDA Approved	Out of Scope	Read
Oxytocin Pitocin · Syntocinon	Posterior pituitary hormone with effects on social bonding, intimacy, and labor.	Hormonal	FDA Approved	Prescribed	Read

P

Peptide	Primary Use	Category	Status	At The Tide
Palmitoyl tetrapeptide-7 PAL-GQPR	Anti-inflammatory cosmetic peptide.	Skin	Cosmetic	Out of Scope	Read
Palmitoyl tripeptide-1 PAL-GHK	Cosmetic collagen-stimulating peptide.	Skin	Cosmetic	Out of Scope	Read
Pasireotide Signifor · Signifor LAR	Somatostatin analog for Cushing disease and acromegaly.	Hormonal	FDA Approved	Out of Scope	Read
PDRN Polydeoxyribonucleotide	Salmon DNA fragments; tissue repair and regeneration.	Recovery	Compounded	Prescribed	Read
PEG-MGF Pegylated mechano growth factor	Muscle repair peptide; preclinical recovery evidence.	Recovery	Research Only	Reference	Read
Pentosan polysulfate Elmiron	Semi-synthetic polysulfated polysaccharide for interstitial cystitis.	GI	FDA Approved	Out of Scope	Read
Plecanatide Trulance	Guanylate cyclase-C agonist for chronic constipation.	GI	FDA Approved	Out of Scope	Read
Pramlintide Symlin	Amylin analog for glycemic control in insulin-dependent diabetes.	Metabolic	FDA Approved	Out of Scope	Read

R

Peptide	Primary Use	Category	Status	At The Tide
Retatrutide LY3437943	Triple GLP-1/GIP/glucagon agonist; late-stage trials.	Metabolic	Research Only	Reference	Read

S

Peptide	Primary Use	Category	Status	At The Tide
Selank TP-7 heptapeptide	Anxiolytic effects via tuftsin-related mechanism.	Cognitive	Compounded	Prescribed	Read
Semaglutide Ozempic · Wegovy · Rybelsus	GLP-1 receptor agonist for metabolic disease and weight management.	Metabolic	FDA Approved	Prescribed	Read
Semax ACTH 4-10 analog	Nootropic peptide; cognitive enhancement research.	Cognitive	Compounded	Prescribed	Read
Sermorelin GRF 1-29	Endogenous GH support with a long clinical use history.	Performance	Compounded	Prescribed	Read
Setmelanotide Imcivree	MC4R agonist for rare genetic obesity.	Metabolic	FDA Approved	Out of Scope	Read
SS-20 Mitochondrial peptide	Mitochondria-targeting peptide; preclinical research.	Longevity	Research Only	Reference	Read
SS-31 Elamipretide · Bendavia	Mitochondria-targeting peptide; cardiovascular and metabolic research.	Longevity	Research Only	Reference	Read

T

Peptide	Primary Use	Category	Status	At The Tide
TA1 (alternate naming) Thymosin alpha-1 alternate designation	Same molecule as Thymosin alpha-1; alternate naming.	Immune	Compounded	Reference	Read
TB-500 Thymosin Beta-4 fragment	Cell migration, angiogenesis, and soft-tissue repair.	Recovery	Compounded	Prescribed	Read
Teduglutide Gattex · Revestive	GLP-2 analog for short bowel syndrome.	GI	FDA Approved	Out of Scope	Read
Teriparatide Forteo · Bonsity	Recombinant PTH 1-34 for severe osteoporosis.	Bone	FDA Approved	Out of Scope	Read
Terlipressin Terlivaz	Vasopressin analog for hepatorenal syndrome.	Cardiovascular	FDA Approved	Out of Scope	Read
Tesamorelin Egrifta	GHRH analog approved for HIV-associated lipodystrophy.	Metabolic	FDA Approved	Prescribed	Read
Thymosin alpha-1 Zadaxin	T-cell modulation; approved internationally for chronic viral and immune conditions.	Immune	Compounded	Prescribed	Read
Thymosin beta-4 Tβ4 (full-length)	Full-length thymosin beta-4 molecule for tissue regeneration.	Recovery	Compounded	Prescribed	Read
Thymulin FTS-Zn	Thymic peptide; immune modulation research.	Immune	Research Only	Reference	Read
Tirzepatide Mounjaro · Zepbound	Dual GIP/GLP-1 agonist; next-generation metabolic therapy.	Metabolic	FDA Approved	Prescribed	Read
Triptorelin Trelstar	GnRH agonist for prostate cancer.	Oncology	FDA Approved	Out of Scope	Read

V

Peptide	Primary Use	Category	Status	At The Tide
Vancomycin Vancocin	Glycopeptide antibiotic for gram-positive infections including MRSA.	Antimicrobial	FDA Approved	Out of Scope	Read
Vasopressin Pitressin · Vasostrict	Posterior pituitary hormone; vasopressor and diabetes insipidus.	Cardiovascular	FDA Approved	Out of Scope	Read

Z

Peptide	Primary Use	Category	Status	At The Tide
Ziconotide Prialt	Synthetic ω-conotoxin; intrathecal analgesic for chronic pain.	Pain	FDA Approved	Out of Scope	Read

A note on this library

This library lists peptides we prescribe or research. Some peptides seen elsewhere online are omitted deliberately — either the human evidence is too thin to prescribe responsibly, or the regulatory pathway does not permit it.